Skin necrosis following intravenous noradrenaline.
D061605:Administration, Intravenous; D005734:Gangrene; D006801:Humans; D009638:Norepinephrine / Q000009:adverse effects*; D012871:Skin Diseases
D009638:Norepinephrine
ARTERENOL/injurious effects; GANGRENE